-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

Benzinga·10/05/2026 17:02:04
Diffusion vocale
Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.